Skip to content

Agilon Health AGL Return on equity

Return on equity at other companies

CVS Health logo
CVS HealthCVS
3.8%-3.2pp
Astrana Health logo
Astrana HealthASTH
3.9%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
3.1%+0.6pp
Alignment Healthcare logo
Alignment HealthcareALHC
12.6%+6.8pp
Clover Health Investments logo
Clover Health InvestmentsCLOV
-16.9%-170pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-52.8%-12.7pp

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Calculated from Agilon Health’s reported figures.

Based on trailing twelve months.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's return on equity?
Agilon Health (AGL) reported return on equity of -104% in Q1 2026.
How has Agilon Health's return on equity changed year-over-year?
Agilon Health's return on equity decreased by 155.7% year-over-year, from -40.7% to -104%.
What is the long-term trend for Agilon Health's return on equity?
Over 3 years (2022 to 2025), Agilon Health's return on equity has grown at a 135.8% compound annual growth rate (CAGR), from -10% to -131%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.